Literature DB >> 14614994

Characteristics of a two-stage screen for incident dementia.

Kathleen M Hayden1, Ara S Khachaturian, JoAnn T Tschanz, Chris Corcoran, Maria Nortond, John C S Breitner.   

Abstract

BACKGROUND AND OBJECTIVES: To avoid costly evaluation of healthy individuals, efficient methods of screening for incident dementia must combine adequate sensitivity and high specificity. Two-stage screening may offer improvements over single-stage methods. We therefore investigated a two-stage screening protocol for incident dementia among 3,308 elderly.
METHODS: We administered the Modified Mini-Mental-State (3MS) or, rarely, Jorm's IQCODE, to a validation sample of 441 high-risk respondents. Informants then completed the Dementia Questionnaire (DQ). Finally, all 441 sample members underwent physical, neurologic, and neuropsychologic assessment. We studied the sensitivity and specificity of the 3MS/IQCODE and DQ using Receiver-Operating Characteristic analyses.
RESULTS: A 3MS cut point of 82/83 (of 100) yielded sensitivity and specificity of 91.5 and 90.1%. With 3MS scores of < or =82, a DQ cut point of 2/3 (of five) yielded conditional sensitivity and specificity of 90.2 and 55.3%. Combining these instruments yielded sensitivity and specificity of 82.5 and 95.6%. Age stratification and use of longitudinal decline score criteria did not materially improve these figures.
CONCLUSIONS: The improved specificity of the two-stage approach offers economies that are attractive, particularly if sensitivity can be enhanced, for example, by examination of a high-risk validation sample.

Entities:  

Mesh:

Year:  2003        PMID: 14614994     DOI: 10.1016/s0895-4356(03)00247-6

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  25 in total

1.  Are clinical diagnoses of Alzheimer's disease and other dementias affected by education and self-reported race?

Authors:  Jeanne A Teresi; Ellen Grober; Joseph P Eimicke; Amy R Ehrlich
Journal:  Psychol Assess       Date:  2012-02-06

2.  A genome-wide linkage analysis of dementia in the Amish.

Authors:  Daniel W Hahs; Jacob L McCauley; Amy E Crunk; Lynne L McFarland; Perry C Gaskell; Lan Jiang; Susan H Slifer; Jeffery M Vance; William K Scott; Kathleen A Welsh-Bohmer; Stephanie R Johnson; Charles E Jackson; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-03-05       Impact factor: 3.568

3.  Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: conceptual framework and example.

Authors:  Jeannie-Marie S Leoutsakos; Alexandra L Bartlett; Sarah N Forrester; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2013-08-15       Impact factor: 21.566

Review 4.  A review of screening tests for cognitive impairment.

Authors:  Breda Cullen; Brian O'Neill; Jonathan J Evans; Robert F Coen; Brian A Lawlor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

5.  Ascertaining dementia-related outcomes for deceased or proxy-dependent participants: an overview of the Women's Health Initiative Memory Study supplemental case ascertainment protocol.

Authors:  Sarah A Gaussoin; Mark A Espeland; John Absher; Barbara V Howard; Beverley M Jones; Stephen R Rapp
Journal:  Int J Geriatr Psychiatry       Date:  2011-03-18       Impact factor: 3.485

6.  Sex Differences in Risk for Alzheimer's Disease Related to Neurotrophin Gene Polymorphisms: The Cache County Memory Study.

Authors:  Joshua Matyi; JoAnn T Tschanz; Gail B Rattinger; Chelsea Sanders; Elizabeth K Vernon; Chris Corcoran; John S K Kauwe; Mona Buhusi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-11-09       Impact factor: 6.053

7.  Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County Study.

Authors:  Muhammad Haroon Burhanullah; JoAnn T Tschanz; Matthew E Peters; Jeannie-Marie Leoutsakos; Joshua Matyi; Constantine G Lyketsos; Milap A Nowrangi; Paul B Rosenberg
Journal:  Am J Geriatr Psychiatry       Date:  2019-05-23       Impact factor: 4.105

8.  Stressful life events and cognitive decline in late life: moderation by education and age. The Cache County Study.

Authors:  Joann T Tschanz; Roxane Pfister; Joseph Wanzek; Chris Corcoran; Ken Smith; Brian T Tschanz; David C Steffens; Truls Østbye; Kathleen A Welsh-Bohmer; Maria C Norton
Journal:  Int J Geriatr Psychiatry       Date:  2012-10-04       Impact factor: 3.485

9.  Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.

Authors:  Kathleen M Hayden; Peter P Zandi; Nancy A West; Joann T Tschanz; Maria C Norton; Chris Corcoran; John C S Breitner; Kathleen A Welsh-Bohmer
Journal:  Arch Neurol       Date:  2009-11

10.  Cognitive Impairment and Progression of CKD.

Authors:  Manjula Kurella Tamura; Kristine Yaffe; Chi-Yuan Hsu; Jingrong Yang; Stephen Sozio; Michael Fischer; Jing Chen; Akinlolu Ojo; Jennifer DeLuca; Dawei Xie; Eric Vittinghoff; Alan S Go
Journal:  Am J Kidney Dis       Date:  2016-03-10       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.